Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie

16. Septembre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

MII (maladie de Crohn/colite)

Troubles fonctionnels

Écriture:

Page 1 de 12249


	Articles 1 - 20 / 244973

	Novel patient-level social determinants of health measure predicts colon cancer outcomes within an integrated health network. Surgery Khan MMM, Boyev A, Joseph EA, Gilberti D, Anees M, Schumacher PE, LeJeune K, Barrett TS, Bartlett DL, Allen CJ. PMID: 42744536 [PubMed - indexed for MEDLINE]
	Pilot feasibility study to deliver low-dose CT lung cancer screening in Scotland: descriptive findings from the LungScot study. BMJ Open Cavers D, Akram AR, Sage EK, Maclay JD, Cowell GW, Mitchell J, Dickie G, Campbell C, Robb KA, Sullivan F, Murchie P, Neilson A, Steele RJC, van Beek EJR, Weller D. PMID: 42744380 [PubMed - indexed for MEDLINE]
	A pilot study: exploring mHealth interventions to increase colorectal cancer knowledge in emerging adult Black men. Ethn Health McGill C, Patev AJ, Sutton AL, Patel P, Palesh O, Thomson MD, Keen LD. PMID: 42744298 [PubMed - as supplied by publisher]
	Biomarker-Guided Treatment Selection in Metastatic Colorectal Cancer: A Critical Review of Established and Emerging Therapies. Crit Rev Oncol Hematol Tojjari A, Pourbahrighesmat S, Alkhazna S, Saeed A. PMID: 42744133 [PubMed - as supplied by publisher]
	Lipid Metabolic Reprogramming in Colorectal Cancer: A Central Hub Integrating Diet, Microenvironment, and Therapy Resistance. Crit Rev Oncol Hematol Zong X, Zu W, Tang D. PMID: 42744131 [PubMed - as supplied by publisher]
	Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023. Lancet Oncol GBD 2023 Africa Cancer Risk Factors Collaborators. PMID: 42743938 [PubMed - as supplied by publisher]
	Screening effectiveness and diagnostic gaps in early-onset colorectal cancer: A systematic review. Cancer Epidemiol Ataca E, Ç, Tarhan MO, Ellidokuz H. PMID: 42743896 [PubMed - as supplied by publisher]
	Oncological impact of adjuvant chemotherapy after rectal cancer excision in the era of FOLFIRINOX-based TNT: A pooled post-hoc analysis of GRECCAR4-PRODIGE23. Eur J Cancer Denost Q, Rouanet P, Teruel E, Borg C, Lelong B, Etienne PL, Maingon P, Rio E, Tuech JJ, Noiret B, Nougaret S, Pezzela V, Gourgou S, Conroy T, GRECCAR and PRODIGE Study Groups. PMID: 42743888 [PubMed - as supplied by publisher]
	Quality of life in patients with RAS wild-type metastatic colorectal cancer treated mFOLFOXIRIâ€¯+â€¯panitumumab versus FOLFOXIRI: A prespecified secondary analysis of the phase II VOLFI AIO-KRK 0109 trial. Eur J Cancer Klingler TM, Martens UM, Riera-Knorrenschild J, Wessendorf S, Ettrich T, Kanzler S, Lugani S, Rohleder E, Stahler A, Hasenburg AA, Held S, Buechner-Steudel P, Atzpodien J, Heinemann V, Geissler M, Modest DP, Werner J. PMID: 42743885 [PubMed - as supplied by publisher]
	Design, synthesis and mechanism study of fluorine-containing bulbocapnine derivatives inducing ferroptosis for anti-colon Cancer therapy. Int Immunopharmacol Duan G, Wang T, Qiu G, Shi J, Xu Y, Chen H, Ma Y, Xie Y, Li S. PMID: 42743873 [PubMed - as supplied by publisher]
	Surface-guided versus conventional setup in rectal cancer radiotherapy: A workflow-level comparison of CBCT-Derived setup corrections. Appl Radiat Isot Zager Marcius V, Boshkovski P, Danevska M, Salmic K. PMID: 42743653 [PubMed - as supplied by publisher]
	Assessing the efficacy of adjuvant chemotherapy in patients with T3N0 gastric cancer. Eur J Surg Oncol Kim KY, Hwang J, Park SH, Cho M, Kim HI, Hyung WJ, Kim YM. PMID: 42743602 [PubMed - as supplied by publisher]
	Machine learning-supported identification of necrosis in colorectal and pancreatic cancer spheroids. PLoS One Lozano MM, Wanzenboeck HD, Prado-López S. PMID: 42743162 [PubMed - indexed for MEDLINE]
	Statin Initiation and Mortality After Colorectal Cancer Treatment. JAMA Netw Open Woo HT, Shin A. PMID: 42742942 [PubMed - indexed for MEDLINE]
	Beyond the barrier: Engineering the tumor-immune-soil nexus-a mechanistic blueprint for integrating Traditional Chinese Medicine with immunotherapy in metastatic colorectal cancer. Med Oncol Sun Y, Li Y, Jiang H, Liu X, Yu S, Liu Y. PMID: 42742786 [PubMed - indexed for MEDLINE]
	Complexity and heterogeneity of vascular anatomy in gastric cancer surgery: a multicenter retrospective cohort study. J Robot Surg Jeong JY, Hwang J, Park SH, Cho M, Kim YM, Kwon IG, Chung JH, Lee S, Hisamori S, Obama K, Hyung WJ. PMID: 42742771 [PubMed - indexed for MEDLINE]
	First Implementation of an All-in-One Solution With Fully Automatic Workflow for Rectal Cancer Based on an Integrated CT-linac. Pract Radiat Oncol Li X, Wang L, Guo R, Yang M, Wang M, Pan Y, Lu S, Ji Y, Zhang W, Jia L, Peng R, Wang J, Wang H. PMID: 42742501 [PubMed - as supplied by publisher]
	Three-dimensional bioprinting for the construction of an in vitro gastrointestinal stromal tumor model. J Appl Biomater Funct Mater Li C, Wang Z, Sun M, Yang J, Qu H, Xue Y, Hu Y. PMID: 42742410 [PubMed - indexed for MEDLINE]
	Three-year risk of colorectal cancer by faecal haemoglobin concentration in subjects with a negative FIT. Ann Ist Super Sanita Puliti D, Gorini G, Caldarella A, Intrieri T, Tumanova Z, Manneschi G, Visioli CB, Mallardi B, Battisti F, Bisanzi S, Sani C, Masala G, Zappa M, Mantellini P. PMID: 42742245 [PubMed - indexed for MEDLINE]
	From receptor biology to therapy: importance of different EGFR mutations in the development of targeted cancer therapies. Immunotherapy Krishnaja U, J N, Sarkar M, Menon KN, Kalita B. PMID: 42742207 [PubMed - as supplied by publisher]

Articles 1 - 20 / 244973

Page 1 de 12249



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité